Viewing Study NCT01607294


Ignite Creation Date: 2025-12-25 @ 1:28 AM
Ignite Modification Date: 2026-05-24 @ 1:00 PM
Study NCT ID: NCT01607294
Status: COMPLETED
Last Update Posted: 2019-03-29
First Post: 2012-04-26
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Single Center Study to Evaluate the Efficacy and Safety of ETC 1002 in Subjects With Type 2 Diabetes
Sponsor: Esperion Therapeutics, Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Hyperlipidemia View
None Type 2 Diabetes View
Keywords: